These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
129 related articles for article (PubMed ID: 31350845)
1. New horizons in reproductive biology: a special issue. Yan W; Clarke H Biol Reprod; 2019 Sep; 101(3):513. PubMed ID: 31350845 [No Abstract] [Full Text] [Related]
2. The tsunami named CRISPR/Cas9. Chneiweiss H Rev Neurol (Paris); 2018; 174(7-8):487-488. PubMed ID: 29779853 [No Abstract] [Full Text] [Related]
3. Major Insights into Microbiology: An Interview with Luciano Marraffini. Davies K; Marraffini L CRISPR J; 2020 Feb; 3(1):5-9. PubMed ID: 32091248 [No Abstract] [Full Text] [Related]
4. A New Class of Medicines through DNA Editing. Porteus MH N Engl J Med; 2019 Mar; 380(10):947-959. PubMed ID: 30855744 [No Abstract] [Full Text] [Related]
6. And Then There Were Three: Discovering the Role of CRISPRs. Vergnaud G CRISPR J; 2019 Dec; 2(6):359-361. PubMed ID: 31860354 [No Abstract] [Full Text] [Related]
7. Profile of Dana Carroll. Viegas J Proc Natl Acad Sci U S A; 2018 Sep; 115(38):9331-9333. PubMed ID: 30201719 [No Abstract] [Full Text] [Related]
8. The plant engineer. Pennisi E Science; 2016 Sep; 353(6305):1220-4. PubMed ID: 27634519 [No Abstract] [Full Text] [Related]
9. Contributions of Ryuzo Yanagimachi to the field of reproductive biology. Ward MA; Ward WS Biol Reprod; 2019 Jan; 100(1):1-7. PubMed ID: 30657895 [No Abstract] [Full Text] [Related]
10. Frontiers in CRISPR. Weidmann AG ACS Chem Biol; 2018 Feb; 13(2):296-304. PubMed ID: 29448764 [TBL] [Abstract][Full Text] [Related]
11. Crossing the germline: CRISPR-Cas9 and our responsibility as reproductive endocrinology and infertility physicians. Kaser DJ; Franasiak JM J Assist Reprod Genet; 2018 Mar; 35(3):399-402. PubMed ID: 29086321 [No Abstract] [Full Text] [Related]
12. A decade of discovery: CRISPR functions and applications. Barrangou R; Horvath P Nat Microbiol; 2017 Jun; 2():17092. PubMed ID: 28581505 [TBL] [Abstract][Full Text] [Related]
13. Prime Time for Genome Editing? Urnov FD N Engl J Med; 2020 Jan; 382(5):481-484. PubMed ID: 31995698 [No Abstract] [Full Text] [Related]
15. [Gene editing in drug discovery and therapeutic innovation]. Galzi JL Med Sci (Paris); 2019 Apr; 35(4):309-315. PubMed ID: 31038108 [TBL] [Abstract][Full Text] [Related]
16. A conversation with George Church. Neill US J Clin Invest; 2019 Apr; 129(4):1403-1404. PubMed ID: 30932914 [No Abstract] [Full Text] [Related]
17. The people behind the papers - Eduardo Leyva-Díaz and Oliver Hobert. Development; 2019 Jun; 146(13):. PubMed ID: 31227643 [TBL] [Abstract][Full Text] [Related]
19. How genome editing could be used in the treatment of cardiovascular diseases. Musunuru K Per Med; 2018 Mar; 15(2):67-69. PubMed ID: 29714123 [No Abstract] [Full Text] [Related]
20. CRISPR/Cas Systems towards Next-Generation Biosensing. Li Y; Li S; Wang J; Liu G Trends Biotechnol; 2019 Jul; 37(7):730-743. PubMed ID: 30654914 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]